Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connected forming a vicious cycle. Firstly, depressed individuals show a higher risk of developing diabetes and patients with diabetes have a higher risk of developing symptoms of depression. Secondly, patients with diabetes have a higher risk of developing severe COVID-19 as well as of experiencing breakthrough infections. Thirdly, in both patients with type 2 diabetes and in COVID-19 survivors the prevalence of depression seems to be increased. Fourthly, lockdown and quarantine measurements during the COVID-19 pandemic has led to an increase in depression. Therefore, it is of importance to increase the awareness of this interface between depression, diabetes and COVID-19. Finally, as symptoms of post-COVID, diabetes and depression may be overlapping, there is a need for educating skilled personnel in the management of these comorbidities.
| Identifer | oai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:90450 |
| Date | 08 April 2024 |
| Creators | Steenblock, Charlotte, Schwarz, Peter E. H., Perakakis, Nikolaos, Brajshori, Naime, Beqiri, Petrit, Bornstein, Stefan R. |
| Publisher | Springer International Publishing |
| Source Sets | Hochschulschriftenserver (HSSS) der SLUB Dresden |
| Language | English |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text |
| Rights | info:eu-repo/semantics/openAccess |
| Relation | 2731-4383, 5, 10.1007/s44192-022-00007-0, info:eu-repo/grantAgreement/Deutsche Forschungsgemeinschaft/Transregios/314061271//TRR 205: Die Nebenniere: Zentrales Relais in Gesundheit und Krankheit, info:eu-repo/grantAgreement/Deutsche Forschungsgemeinschaft/Internationale Graduiertenkollegs/288034826//GRK 2251: Immunologische und zellbasierte Strategien bei metabolischen Erkrankungen |
Page generated in 0.0016 seconds